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Timolol Activates the Enzyme Activities of 
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ABSTRACT: Timolol, a beta-blocker, has been shown to be an effective ocular hypotensive 
agent when used alone or with carbonic anhydrase inhibitor on ocular hypertensive or open 
angle glaucoma patients. The effect of timolol hemihydrate on the CO2 hydration activities 
of human carbonic anhydrase (HCA) I and II and its reaction mechanism were investigated. 
Timolol activates the enzyme activities of HCA I and HCA II.  In HCA I and II, the enzyme 
kinetic results clearly showed that timolol increases the value of Vmax but does not influence 
the value of Km.  The enzyme kinetic method showed that timolol noncompetitively activates 
HCA I and II activities through the formation of a ternary complex consisting of the enzyme, 
the substrate, and timolol.  These results indicate that timolol binds apart from the narrow 
cavity of the active site.
   AutoDocking results showed that timolol binds at the entrance of the active site cavity in 
a region where the proton shuttle residue, His 64, of HCA I or II, is placed.  The enzyme 
kinetic and AutoDocking results showed that timolol might weakly bind near the proton 
shuttle residue, His 64, to accelerate the proton transfer rate from His 64 to the buffer 
components. It is known that efficient activators of carbonic anhydrase possess a bulky 
aromatic/heterocyclic moiety and a primary/secondary amino group in their molecular 
structure. Timolol has a heterocyclic moiety and a secondary amino group, which are typical 
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